Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06127537
Other study ID # 134/2020
Secondary ID IB20186134/20201
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2021
Est. completion date June 16, 2024

Study information

Verified date November 2023
Source Universidad de Extremadura
Contact Francisco J Rodríguez Velasco, PhD
Phone +34 924289839
Email fcorodriguezv@unex.es
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This randomised study evaluates the efficacy of health education and therapeutic group factors on cardiac rehabilitation and quality of life in coronary patients attending cardiac rehabilitation programmes in Extremadura.


Description:

Cardiac rehabilitation has been shown to be effective in improving the quality of life of patients who have suffered a cardiovascular event, as well as in preventing future cardiovascular events, demonstrating an increase in survival of between 20% and 30%, with a Class IA recommendation. Due to the prevalence of cardiovascular disease, both nationally and globally, it is important to study the benefits of these cardiac rehabilitation programmes in order to encourage their use. However, several studies have shown that for the programme to be effective, 5% to 10% weight loss must be achieved in patients, adequate nutritional education must be implemented, and behavioural and psychological intervention programmes must be incorporated in order to have an impact on adherence, psychological well-being, and coping with exercise intolerance. This project aims to study the effectiveness of health education and therapeutic group factors in cardiac rehabilitation and on quality of life in coronary patients in Cardiac Rehabilitation Units in Extremadura, including in the analysis anthropometric and body composition, nutritional, cognitive, emotional and lifestyle factors, which could act as mediators of cardiac function, reactivity to neuro-cardiovascular stress, anxiety, depression, anger-hostility, rehospitalisation, adherence, and adherence to treatment.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date June 16, 2024
Est. primary completion date January 31, 2024
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Diagnosis of coronary heart disease, referred to the "Cardiac Prevention and Rehabilitation Unit". Exclusion Criteria: - Patients with disabling psychiatric disorders. - Existence of pacemaker or automatic defibrillator. - Presence of pregnancy or breastfeeding. - Presence of medical conditions related to oncological conditions requiring chronic treatment with drugs or other substances. - Any condition that, in the opinion of the investigators, would disqualify the subject from participation in the study.

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Therapeutic Intervention Group
The therapeutic group factors that are worked on in the group session with a psychologist are: Altruism. Cohesion: feeling of belonging and acceptance in a group. Universality: identification with the feelings, ideas or problems of the other group members. Interpersonal-internalisation learning: the patient understands himself/herself by sharing his/her experience with the group. Interpersonal-externalisation learning: the group offers the patient the possibility to express his own experience and to change his attitudes towards others. Counselling. Identification: assumption of behavioural patterns of other members as one's own. Reactualisation of the family experience. Understanding of one's own internal motivations. Reciprocal stimulation: the improvement of other members encourages them to solve or approach their problems in a more favourable way. Existential factors: empowerment of the individual.

Locations

Country Name City State
Spain Servicio Extremeño de Salud Badajoz

Sponsors (2)

Lead Sponsor Collaborator
Universidad de Extremadura European Regional Development Fund

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in basal cardiac function and stress reactivity at 8 weeks Changes in heart rate (bpm) are monitored at rest, during treadmill or stationary bicycle exercise and in recovery (by ergometry - PEG). 0 and 8 weeks
Primary Changes in blood pressure over 8 weeks Changes in blood pressure (mmHg) are monitored at rest, during exercise on a treadmill or stationary bike and in recovery. (by ergometry - PEG). 0 and 8 weeks
Primary Change in cardiovascular health indicators over 8 weeks Change in the Fuster-BEWAT score (FBS): this index is derived from cardiovascular health indicators blood pressure (mmHg), physical activity (METs), body mass index (kg/m2), fruit and vegetable consumption, and smoking status; 0-1 indicates poor cardiovascular health; 2-3, intermediate; and 4-5, ideal. 0 and 8 weeks
Primary Changes in physical activity at 8 weeks Changes in physical activity using the International Physical Activity Questionnaire (IPAQ): Weekly activity is recorded in Mets (Metabolic Task Equivalent or Metabolic Rate Units) per minute per week (Cat 1 - Low: <25 Mets / Cat 2 - Moderate: 25-600 Mets / Cat 3 - High: >1500 Mets). 0 and 8 weeks
Primary Changes in maximum prehensile strength over 8 weeks Changes in maximal upper limb prehensile strength by dynamometry (kg). 0 and 8 weeks
Primary Changes in quality of life indicators over 8 weeks Changes in the Spanish Quality of Life Questionnaire scores in post-infarction patients will be studied. The score per item ranges from 1 (never) to 5 (always). The minimum score is 40 (best health status) and the maximum 200 points (worst health status). 0 and 8 weeks
Primary Changes in Physical Function quality score over 8 weeks Items from the SF36 (Short Form 36) survey. The analysis of the responses is based on the calculation for domain with a scale between 0 (worst health status) and 100 (best health status), after coding, aggregation and transformation of the items that make up each domain. 0 and 8 weeks
Primary Changes in Physical Role quality score over 8 weeks Items from the SF36 (Short Form 36) survey. The analysis of the responses is based on the calculation for domain with a scale between 0 (worst health status) and 100 (best health status), after coding, aggregation and transformation of the items that make up each domain. 0 and 8 weeks
Primary Changes in Bodily Pain quality score over 8 weeks Items from the SF36 (Short Form 36) survey. The analysis of the responses is based on the calculation for domain with a scale between 0 (worst health status) and 100 (best health status), after coding, aggregation and transformation of the items that make up each domain. 0 and 8 weeks
Primary Changes in General Health quality score over 8 weeks Items from the SF36 (Short Form 36) survey. The analysis of the responses is based on the calculation for domain with a scale between 0 (worst health status) and 100 (best health status), after coding, aggregation and transformation of the items that make up each domain. 0 and 8 weeks
Primary Changes in Vitality quality score over 8 weeks Items from the SF36 (Short Form 36) survey. The analysis of the responses is based on the calculation for domain with a scale between 0 (worst health status) and 100 (best health status), after coding, aggregation and transformation of the items that make up each domain. 0 and 8 weeks
Primary Changes in Social Function quality score over 8 weeks Items from the SF36 (Short Form 36) survey. The analysis of the responses is based on the calculation for domain with a scale between 0 (worst health status) and 100 (best health status), after coding, aggregation and transformation of the items that make up each domain. 0 and 8 weeks
Primary Changes in Emotional Role and Mental Health quality score over 8 weeks Items from the SF36 (Short Form 36) survey. The analysis of the responses is based on the calculation for domain with a scale between 0 (worst health status) and 100 (best health status), after coding, aggregation and transformation of the items that make up each domain. 0 and 8 weeks
Primary Changes in Health perception over 8 weeks Changes in health perception will be calculated from the score of the Spanish Quality of Life Questionnaire in post-infarction patients. The score per item ranges from 1 (never) to 5 (always). The minimum score is 40 (best health status) and the maximum 200 points (worst health status). 0 and 8 weeks
Secondary Changes in body weight composition over 8 weeks Total patient weight are measured as a kilogram (kg). 0 and 8 weeks
Secondary Changes in body fat mass composition over 8 weeks Total patient body fat mass are measured as a kilogram (kg). 0 and 8 weeks
Secondary Changes in body fat-free mass composition over 8 weeks Total patient body fat-free mass are measured as a kilogram (kg). 0 and 8 weeks
Secondary Changes in estimated total body water composition over 8 weeks Total patient estimated total body water are measured as a kilogram (kg). 0 and 8 weeks
Secondary Changes in protein composition over 8 weeks Total patient protein are measured as a kilogram (kg). 0 and 8 weeks
Secondary Changes in bone mineral composition over 8 weeks Total patient bone mineral are measured as a kilogram (kg). 0 and 8 weeks
Secondary Changes in Body Mass Index over 8 weeks Weight (kg) and Height (m) will be combined to report BMI in kg/m^2. 0 and 8 weeks
Secondary Changes in CUN-BAE index over 8 weeks CUN-BAE are calculated as -44.988+(0.503×age) +(10.689 ×sex) +(3.172×BMI) -(0.026×BMI2) +(0.181×BMI×sex) -(0.02×BMI×age) -(0.005×BMI2 ×sex) +(0.00021×BMI2×age), where male=0 and female=1 for sex, measuring age in years. 0 and 8 weeks
Secondary Changes in phase angle bioimpedance over 8 weeks Phase angle is measured in degrees (º). 0 and 8 weeks
Secondary Changes in the percentage of carbohydrates ingested over 8 weeks A standardised food consumption questionnaire will be used to assess dietary habits, which collects food intake over 7 days. The weekly nutrient intake will be transformed into "Food Composition Tables". The value obtained will be the percentage of carbohydrates (%). 0 and 8 weeks
Secondary Changes in the percentage of fat ingested over 8 weeks A standardised food consumption questionnaire will be used to assess dietary habits, which collects food intake over 7 days. The weekly nutrient intake will be transformed into "Food Composition Tables". The value obtained will be the percentage of fat ingested (%). 0 and 8 weeks
Secondary Changes in the percentage of protein ingested over 8 weeks A standardised food consumption questionnaire will be used to assess dietary habits, which collects food intake over 7 days. The weekly nutrient intake will be transformed into "Food Composition Tables". The value obtained will be the percentage of protein ingested (%). 0 and 8 weeks
Secondary Changes in the percentage of vitamins ingested over 8 weeks A standardised food consumption questionnaire will be used to assess dietary habits, which collects food intake over 7 days. The weekly nutrient intake will be transformed into "Food Composition Tables". The value obtained will be the percentage of vitamins ingested (%). 0 and 8 weeks
Secondary Changes in kilocalorie intake over 8 weeks A standardised food consumption questionnaire will be used to assess dietary habits, which collects food intake over 7 days. The weekly nutrient intake shall be transformed into "Food composition tables". The value obtained will be the number of kilocalories ingested (kcal). 0 and 8 weeks
Secondary Changes in adherence to the Mediterranean diet over 8 weeks Changes in adherence to the Mediterranean diet. This will be studied using the Mediterranean Diet Adherence Questionnaire, which consists of 15 items with values ranging from <9 (low adherence) to >=9 (good adherence). 0 and 8 weeks
Secondary Changes in erythrocyte parameters over 8 weeks Erythrocyte parameters are measured as a percentage [%] 0 and 8 weeks
Secondary Changes in glucose level over 8 weeks Glucose is measured as a milligrams per decilitre [mg/dl] 0 and 8 weeks
Secondary Changes in plasma albumin parameters over 8 weeks Plasma albumin are measured as a [g/dl] 0 and 8 weeks
Secondary Changes in total lymphocyte over 8 weeks Total lymphocyte count are measured as a percentage [%] 0 and 8 weeks
Secondary Changes in total triglycerides levels over 8 weeks Total lymphocyte count are measured as a milligrams per decilitre [mg/dl] 0 and 8 weeks
Secondary Changes in total cholesterol level over 8 weeks Total cholesterol are measured as a milligrams per decilitre [mg/dl] 0 and 8 weeks
Secondary Changes in high-density lipoproteins levels over 8 weeks High-density lipoproteins are measured as a milligrams per decilitre [mg/dl] 0 and 8 weeks
Secondary Changes in low-density lipoproteins levels over 8 weeks Low-density lipoproteins are measured as a milligrams per decilitre [mg/dl] 0 and 8 weeks
Secondary Changes in psychological parameters over 8 weeks Changes in STATE-TRAIT ANXIETY scores measured by the State-Trait Anxiety Questionnaire (STAI). It consists of 40 items divided into 2 subscales: trait and state, with Likert-type responses from 0 to 3. The score can range from 0 to 60. There are no cut-off points, but the direct scores are transformed into centiles according to sex and age. 0 and 8 weeks
Secondary Changes in adherence over 8 weeks Change in Morisky Green Test scores. It consists of 4 items. The patient is considered to be compliant if he/she answers correctly to all 4 items. Parameter will be measured as compliant / not compliant- 0 and 8 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05956912 - Implementing Group Metacognitive Therapy in Cardiac Rehabilitation Services (PATHWAY-Beacons)
Active, not recruiting NCT05773287 - Targeted Health Coaching to Improve Physical Activity Post-Structured Cardiac Rehabilitation N/A
Completed NCT05551429 - Factors Related to Participation in Cardiac Rehabilitation in Patients With Acute Coronary Syndrome
Completed NCT02542163 - Pilot Evaluation of the NimbleHeart Harness System in Cardiac Rehabilitation (PEN-CR) N/A
Not yet recruiting NCT05989594 - Home-based Mobile Guided Exercise-based Cardiac Rehabilitation Among Patients Undergoing TAVR N/A
Active, not recruiting NCT05026957 - A Digitally-Supported Shared Decision Making Approach for Coronary Artery Disease Patients During Cardiac Rehabilitation N/A
Recruiting NCT03734185 - Cardiac Rehabilitation: From Hospital to Municipal Setting. N/A
Recruiting NCT05826587 - Cardiac Rehabilitation Mobile-Health Fall Risk Prevention Intervention N/A
Completed NCT03174106 - Longterm Follow-up of Cardiac Patients With an Smartphone-Application N/A
Recruiting NCT05725655 - Hot Water Immersion After Myocardial Infarction N/A
Not yet recruiting NCT05019157 - Cardiac Telerehabilitation Effectiveness Using Wearable Sensors N/A
Recruiting NCT06025526 - Effectiveness of the Aktivplan Digital Intervention (ACTIVE-CaRe Pilot) N/A
Recruiting NCT05099692 - CHD Patient's Concern on Cardiac Rehabilitation
Completed NCT06306235 - Are Non-participants of Conventional Centre-based Cardiac Rehabilitation Willing to Participate in Cardiac Telerehabilitation?
Recruiting NCT06039969 - Evaluate Aerobic Exercise on Myocardial Fibrosis and Intestinal Flora in Dilated Cardiomyopathy Diagnosed First Time.
Not yet recruiting NCT06065319 - Wearables and Cardiac Rehabilitation
Completed NCT04738383 - Feasibility and Acceptance of Changes in Medical Supervision of Exercise Groups in Cardiac Rehabilitation N/A
Active, not recruiting NCT03922529 - Modified Application of Cardiac Rehabilitation for Older Adults N/A
Completed NCT00956657 - Improving Cardiac Rehabilitation Session Attendance: A Randomised Controlled Trial N/A
Completed NCT03991715 - Sustaining Physical Activity Following Cardiac Rehabilitation Completion N/A